Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan
| Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan |
| Autore | Vermorken Jan B |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Springer Nature, 2021 |
| Descrizione fisica | 1 online resource (IX, 373 p. 39 illus., 33 illus. in color.) |
| Disciplina | 616.994 |
| Soggetto topico |
Oncology
Radiotherapy Cancer - Surgery Surgical Oncology Càncer de coll Càncer de cap Cirurgia oncològica |
| Soggetto genere / forma | Llibres electrònics |
| Soggetto non controllato |
Oncology
Radiotherapy Surgical Oncology Internal Medicine Radiology Surgery Nasopharynx cancer Head and Neck Squamous Cell Cancer non-oropharyngeal head and neck cancer predictive biomarkers liquid biopsies induction chemotherapy immunotherapy precision medicine HNSCC Open Access |
| ISBN | 3-030-63234-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) -- Promising biomarkers for early diagnosis and prognosis prediction in HNS -- Biomarkers to predict radiotherapy toxicity -- Biomarkers for hypoxia, HPVness and proliferation from imaging perspective -- Mechanism of cetuximab resistance and how to overcome it -- The role of liquid biopsy for monitoring disease evolution -- NK cells in immunotherapy: how important are they? -- Biomarkers for immune modulatory treatment in HNSCC -- Primary disease (1) -- Novel approaches in surgical management of HNSCC -- The surgical approach to elderly patients with HNSCC -- The nonsurgical approach to locoregionally advanced HNSCC -- High-dose three-weekly or low-dose weekly cisplatin during radiation, what to prefer? -- Primary disease (2) -- Where and when to use induction chemotherapy? -- Prognostic role of p16/HPV in non-oropharyngeal head and neck cancer -- Is there a role for neoadjuvant targeted and immunotherapies? -- Is there a role for adjuvant targeted and immunotherapies? -- Optimal supportive measures during primary treatment -- Precision Medicine in head and neck cancer: myth or reality -- Recurrent and / or metastatic disease -- Salvage surgery: candidates, safe reconstruction, and results? -- Re-irradiation for local relapses or second primaries: when and how? -- New promising targeted agents in first and second-line settings -- Update of immune therapies in recurrent/metastatic HNSCC -- Special Issue -- Patients with rare head neck cancers: do they need a different approach? .-Nasopharynx cancer -- New epidemiological aspects -- New developments in the management of nasopharyngeal carcinoma -- New drugs for recurrent/metastatic nasopharynx cancer. |
| Record Nr. | UNINA-9910484360603321 |
Vermorken Jan B
|
||
| Springer Nature, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Malignant Mesothelioma
| Malignant Mesothelioma |
| Autore | L. Pouliquen Daniel |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (328 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
well-differentiated papillary mesothelioma
WDPM malignant mesothelioma DNA sequencing mutation mesothelioma tumor suppressor targeted therapy immunotherapy biomarkers proteomics macrophage-capping protein fatty acid-binding protein laminin subunit beta-2 selenium-binding protein 1 carcinogenesis malignant pleural mesothelioma asbestos exposure DNA methylation lymphocyte-to-monocyte ratio epigenome-wide analysis survival analysis metabolomics radiotherapy cancers inflammation infiltrating immune cells prognostic biomarker predictive biomarker immune therapy VATS extrapleural pneumonectomy pleurectomy decortication therapy response survival FDG PET-CT mesothelium oxidative stress redox-sensitive factors asbestos carbon nanotubes protein-protein interactions systems biology network analysis drug repurposing pleural mesothelioma gene expression immunogenicity sarcomatoid epithelioid first line meta-analysis systematic review MPM lurbinectedin DNA damage response histotype Hippo pathway NF2 BAP1 CDKN2A PTCH1 SETD2 MTAP liquid biopsies circulating tumor DNA plasma cancer-specific mutations genomics cancer biomarkers tumor microenvironment tumor-associated macrophages dendritic cells immunohistochemistry interaction analysis pleural effusion |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557359303321 |
|
L. Pouliquen Daniel
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of miRNAs in Cancer : Analysis of Their Targetome
| Role of miRNAs in Cancer : Analysis of Their Targetome |
| Autore | Navarro Alfons |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (302 p.) |
| Soggetto topico |
Medicine
Oncology |
| Soggetto non controllato |
miR526b
miR655 breast cancer angiogenesis lymphangiogenesis EP4 PI3K/Akt microRNA-361 EMT tumor microenvironment cancer diagnosis cancer treatment Bladder cancer microRNA genetic marker progression ccRCC prognostic biomarker miRNA transcription factor interplay microRNAs exosomes liquid biopsy metastasis cancer liquid biopsies tumor SNAIL (SNAI1) transcription factor epithelial to mesenchymal transition (EMT) long non-coding RNAs (lncRNAs) circular RNAs viral miRNAs EBV HHV-8 HPV HCV HBV MCPyV glioblastoma MGMT survival radiotherapy chemotherapy temozolomide translational medicine oncomiRNA post-transcriptional regulation immune regulation adrenocortical carcinoma micro RNA non-coding RNA thyroid carcinoma radioactive iodine drug resistance prognosis Burkitt lymphoma miR-378a-3p cell growth pancreatic cancer radioresistance personalized medicine biomarker target |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Role of miRNAs in Cancer |
| Record Nr. | UNINA-9910566464803321 |
|
Navarro Alfons
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||